SCHEMBL29575

SCHEMBL29575

CCCCCOP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3817506 0.97 THRB (0.50)
SCHEMBL27511841 0.97 THRB (0.50)
SCHEMBL11363997 0.97 THRB (0.50)
SCHEMBL10110913 0.97 THRB (0.50)
SCHEMBL3821892 0.97
SCHEMBL3822818 0.97
Hydrochloric Acid SCHEMBL8076192 0.97
SCHEMBL14468772 0.97 THRB (0.50)
SCHEMBL13040134 0.97 THRB (0.50)
SCHEMBL68243 0.97 THRB (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026273-A1 THERAPY FOR REDUCED OTOTOXICITY FROM CHEMOTHERAPEUTIC AGENT WITH PENTAAZA MACROCYCLIC RING COMPLEX GALERA LABS, LLC (US) 2024-02-01 WO claimed
US-20230218633-A1 METHODS OF TREATING ORAL MUCOSITIS GALERA LABS, LLC 2023-07-13 US claimed
US-20230158042-A1 COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT BIOSSIL INC. (CA) 2023-05-25 US claimed
US-20230149358-A1 COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT BIOSSIL INC. (CA) 2023-05-18 US claimed
EP-4157242-A1 COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT Galera Labs, LLC (US) 2023-04-05 EP claimed
US-11612608-B2 Methods of treating oral mucositis GALERA LABS, LLC (US) 2023-03-28 US claimed
WO-2023009500-A1 PENTAAZA MACROCYCLIC RING COMPLEX FOR ENHANCED SURGICAL TREATMENT GALERA LABS, LLC (US) 2023-02-02 WO claimed
US-20220227798-A1 MANUFACTURE METHOD FOR AQUEOUS FORMULATION OF MANGANESE-CONTAINING COORDINATION COMPLEX, FORMULATION, AND METHOD OF TREATMENT GALERA LABS, LLC 2022-07-21 US claimed
CN-114456167-A Azafluoranthene derivative and application thereof 上海八亿时空先进材料有限公司 2022-05-10 CN claimed
US-20220118119-A1 COMBINATION CANCER IMMUNOTHERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX BIOSSIL INC. (CA) 2022-04-21 US claimed
EP-0598753-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1994-06-01 EP claimed
US-5298541-A Molding materials HOECHST AKTIENGESELLSCHAFT (DE) 1994-03-29 US claimed
WO-1993002090-A1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO COMPANY (US) 1993-02-04 WO claimed
EP-0524161-A1 Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide MONSANTO COMPANY (US) 1993-01-20 EP claimed
US-4520190-A Preparation of polyamide from dinitrile, diamine and water with P catalyst THE STANDARD OIL COMPANY (US) 1985-05-28 US claimed
US-4490521-A Preparation of spinnable polyamide from dinitrile/diamine/water with metal salt of oxygenated phosphorus compound catalyst THE STANDARD OIL COMPANY (US) 1984-12-25 US claimed
US-4391761-A Process for the production of aryl phosphonyl compounds BAYER AKTIENGESELLSCHAFT (DE) 1983-07-05 US claimed
EP-0043482-B1 PROCESS FOR PREPARING ARYL-PHOSPHONYL COMPOUNDS BAYER AG (DE) 1983-05-25 EP claimed
US-4263224-A USING PHOSPHINITE CATALYST, PHOSPHONITE SCAVENGER IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-04-21 US claimed
US-3944603-A AND PROPIONIC ANHYDRIDE FROM ETHYLENE AND CARBON MONOXIDE, IRIDIUM COMPLEX CATALYST MONSANTO COMPANY (US) 1976-03-16 US claimed